Aspen Aerogels (NYSE:ASPN) Trading Up 8.2% – Still a Buy?

Aspen Aerogels, Inc. (NYSE:ASPN) was up 8.2% on Monday . The stock traded as high as $14.11 and last traded at $14.09. Approximately 318,315 shares traded hands during trading, a decline of 69% from the average daily volume of 1,019,517 shares. The stock had previously closed at $13.02.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ASPN shares. Roth Mkm lowered their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. Barclays lowered their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Piper Sandler dropped their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $30.00.

Aspen Aerogels Stock Up 6.6 %

The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.14 billion, a P/E ratio of 1,389.39 and a beta of 2.14. The company’s 50 day moving average price is $14.46 and its two-hundred day moving average price is $21.08.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC bought a new stake in Aspen Aerogels during the 3rd quarter valued at $10,126,000. Franklin Resources Inc. boosted its position in Aspen Aerogels by 5.3% during the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after purchasing an additional 1,483 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Aspen Aerogels in the third quarter valued at about $498,000. Geode Capital Management LLC raised its holdings in Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of Aspen Aerogels by 333.8% during the third quarter. Barclays PLC now owns 92,302 shares of the construction company’s stock valued at $2,557,000 after buying an additional 71,024 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.